Investor's Fiduciary Advisor Network’s Pfizer PFE Stock Holding History

Investor's Fiduciary Advisor Network’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$805K	Sell	33,462 -9,533	-22%	-$249K	0.27%	86
2026 Q1	$1.21M	Sell	42,995 -3,910	-8%	-$104K	0.37%	78
2025 Q4	$1.17M	Sell	46,905 -2,742	-6%	-$69.1K	0.25%	95
2025 Q3	$1.26M	Buy	49,647 +2,050	+4%	+$50.6K	0.43%	65
2025 Q2	$1.15M	Buy	47,597 +18,390	+63%	+$429K	0.43%	65
2025 Q1	$740K	Buy	29,207 +4,141	+17%	+$108K	0.35%	77
2024 Q4	$664K	Buy	+25,066	New	+$680K	0.25%	97

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Investor's Fiduciary Advisor Network's PFE Position: Q2 2026 in Review

Investor's Fiduciary Advisor Network reduced its Pfizer (PFE) stake by 22% in Q2 2026, selling an estimated $249K and leaving 33,462 shares worth $805K. The position accounts for 0.27% of the portfolio, ranked #86.

Investor's Fiduciary Advisor Network first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.26M in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Investor's Fiduciary Advisor Network held 33,462 shares of Pfizer worth $805K as of Q2 2026.
Investor's Fiduciary Advisor Network sold 9,533 Pfizer shares in Q2 2026, an estimated $249K.
Pfizer made up 0.27% of Investor's Fiduciary Advisor Network's portfolio in Q2 2026, its #86 holding.
Investor's Fiduciary Advisor Network first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Investor's Fiduciary Advisor Network's Pfizer position peaked at $1.26M in Q3 2025.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Investor's Fiduciary Advisor Network's 13F filing for Q2 2026, filed 13 Aug 2026.